Sign in

CIK 0001422143

  • Non-accelerated filer
  • Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547851
Phone
+1 858-500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
  1. 4 Open-market sale CCO & Chief Strategy Officer sold 1,906 shares at $13.89 ($26,474)
  2. 4 Open-market sale SVP, Finance & Accounting sold 1,548 shares at an average $13.89 ($21,502)
  3. 4 Open-market sale Chief Medical Officer sold 9,225 shares at an average $13.88 ($128,033)
  4. 4 Open-market sale Chief Legal Officer sold 2,100 shares at $15.22 ($31,965)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Grant or award SVP, Finance & Accounting acquired 8,390 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Grant or award CFO, CBO acquired 21,900 shares (grant or award)
  15. 4 Grant or award Chief Operating Officer acquired 21,900 shares (grant or award)
  16. 4 Grant or award Chief Commercial Officer acquired 21,900 shares (grant or award)
  17. 4 Grant or award Chief Medical Officer acquired 36,900 shares (grant or award)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 7 of 14 · 277 filings